These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38646959)

  • 1. Current state and advances in desensitization for peanut allergy in pediatric age.
    Foti Randazzese S; Panasiti I; Caminiti L; Catamerò F; Landi M; De Filippo M; Votto M; Olcese R; Favuzza F; Giovannini M; Barberi S
    Pediatr Allergy Immunol; 2024 Apr; 35(4):e14127. PubMed ID: 38646959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.
    Dupont C; Burks AW; Fleischer DM; Bee KJ; Chainani S; Sampson HA
    Expert Rev Clin Immunol; 2024 Jun; 20(6):623-633. PubMed ID: 38323337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peanut allergen powder (Palforzia).
    Med Lett Drugs Ther; 2020 Mar; 62(1593):33-34. PubMed ID: 32555119
    [No Abstract]   [Full Text] [Related]  

  • 5. Peanut Allergen Powder (Palforzia) for Peanut Allergy.
    Erlich D
    Am Fam Physician; 2022 Jan; 105(1):20-21. PubMed ID: 35029941
    [No Abstract]   [Full Text] [Related]  

  • 6. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
    Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
    J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Trend in Immunotherapy for Peanut Allergy.
    Joo Chan C; Richardo T; Lim RLH
    Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peanut allergy and oral immunotherapy.
    Lee TH; Chan JKC; Lau PC; Luk WP; Fung LH
    Hong Kong Med J; 2019 Jun; 25(3):228-234. PubMed ID: 31178442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the management of peanut allergy (oral immunotherapy and epicutaneous immunotherapy).
    Wang J
    Allergy Asthma Proc; 2020 Jan; 41(1):5-9. PubMed ID: 31888777
    [No Abstract]   [Full Text] [Related]  

  • 10. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current opinion and review on peanut oral immunotherapy.
    Deol S; Bird JA
    Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial.
    Michaud E; Evrard B; Pereira B; Rochette E; Bernard L; Rouzaire PO; Gourdon-Dubois N; Merlin E; Fauquert JL
    Trials; 2015 Apr; 16():197. PubMed ID: 25925398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peanut (
    Casale TB; Irani AM
    Expert Rev Clin Immunol; 2023 Mar; 19(3):253-265. PubMed ID: 36524617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy approaches for peanut allergy.
    Kim EH; Patel C; Burks AW
    Expert Rev Clin Immunol; 2020 Feb; 16(2):167-174. PubMed ID: 31928251
    [No Abstract]   [Full Text] [Related]  

  • 15. Epicutaneous immunotherapy with Viaskin
    Stukus DR; Gupta R; Mack D; Mandelbaum L; Siri D; Hernandez-Trujillo V; Sampson HA
    Immunotherapy; 2024 Jan; 16(1):5-13. PubMed ID: 38112107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose immunotherapy in very young children to treat peanut allergy.
    Vickery BP
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging Therapies for Peanut Allergy.
    Hong TS; Hu A; Fahim G; Hermes-DeSantis ER
    J Pharm Pract; 2022 Apr; 35(2):289-297. PubMed ID: 33148108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
    Fleischer DM; Greenhawt M; Sussman G; Bégin P; Nowak-Wegrzyn A; Petroni D; Beyer K; Brown-Whitehorn T; Hebert J; Hourihane JO; Campbell DE; Leonard S; Chinthrajah RS; Pongracic JA; Jones SM; Lange L; Chong H; Green TD; Wood R; Cheema A; Prescott SL; Smith P; Yang W; Chan ES; Byrne A; Assa'ad A; Bird JA; Kim EH; Schneider L; Davis CM; Lanser BJ; Lambert R; Shreffler W
    JAMA; 2019 Mar; 321(10):946-955. PubMed ID: 30794314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.
    Chin SJ; Vickery BP; Kulis MD; Kim EH; Varshney P; Steele P; Kamilaris J; Hiegel AM; Carlisle SK; Smith PB; Scurlock AM; Jones SM; Burks AW
    J Allergy Clin Immunol; 2013 Aug; 132(2):476-8.e2. PubMed ID: 23534975
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
    O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
    Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.